Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kuba Retecki"'
Autor:
Leszek Pączek, Radoslaw Zagozdzon, Karl-Johan Malmberg, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Anna Burdzinska, Angelika Muchowicz, Agnieszka Goral, Andriy Zhylko, Karolina Soroczynska, Kuba Retecki, Marta Krawczyk, Marta Klopotowska, Zofia Pilch, Sébastien Wälchli, Magdalena Winiarska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/2bc9113457e748bd8bdb6676f28d3abe
Autor:
Andriy Zhylko, Marta Klopotowska, Zofia Pilch, Malgorzata Firczuk, Aleksander Slusarczyk, Malgorzata Bajor, Herman Netskar, Dariusz Plewczynski, Karl-Johan Malmberg, Agnieszka Goral, Iwona Baranowska, Agnieszka Graczyk-Jarzynka, Blanka Sharma, Kuba Retecki, Joanna Domagala, Radoslaw Zagozdzon, Mieszko Lachota, Michal Lazniewski, Karolina Soroczynska, Madison N. Temples, Katsiaryna Marhelava, Agnieszka Kraft, Kavita Ramji, Marta Krawczyk, Magdalena Winiarska
Publikováno v:
Cancer Immunology Research. 10:228-244
Oxidative stress, caused by the imbalance between reactive species generation and the dysfunctional capacity of antioxidant defenses, is one of the characteristic features of cancer. Here, we quantified hydrogen peroxide in the tumor microenvironment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368fd1c7d058b76a73b3c5c236abef07
https://doi.org/10.1158/2326-6066.cir-20-1023
https://doi.org/10.1158/2326-6066.cir-20-1023
Autor:
Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Anna Burdzinska, Angelika Muchowicz, Agnieszka Goral, Andriy Zhylko, Karolina Soroczynska, Kuba Retecki, Marta Krawczyk, Marta Klopotowska, Zofia Pilch, Leszek Paczek, Karl-Johan Malmberg, Sébastien Wälchli, Magdalena Winiarska, Radoslaw Zagozdzon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
BackgroundImmune checkpoint inhibitors and chimeric antigen receptor (CAR)-based therapies have transformed cancer treatment. Recently, combining these approaches into a strategy of PD-L1-targeted CAR has been proposed to target PD-L1high tumors. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73294b6c11d91448aad4596101477505
https://jitc.bmj.com/content/10/1/e002500.full
https://jitc.bmj.com/content/10/1/e002500.full
Publikováno v:
Cancers, Vol 13, Iss 6012, p 6012 (2021)
Cancers
Cancers
Simple Summary Immunotherapy is a rapidly advancing field in breast cancer treatment, however, it encounters many obstacles that leave open gateways for breast cancer cells to resist novel immunotherapies. It is believed that the tumor microenvironme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b46a323e2cc268908c6468e2f860d123
https://doi.org/10.3390/cancers13236012
https://doi.org/10.3390/cancers13236012